Award
Delivery Order #SPE2D326F7364
Short-Term Delivery Order for Ketorolac Vials to Fresenius Kabi, LLC
Buyer
Defense Logistics Agency
Award Amount
$106.57
Ceiling
$106.57
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2D326F7364
NAICS
325411
This award is a short-term delivery order contract issued to Fresenius Kabi, LLC, a company specializing in pharmaceutical manufacturing and distribution. The contract involves the procurement of Ketorolac 30 MG/ML vials, a critical medication used for pain management. The award supports ongoing U.S. Department of Defense medical supply needs, ensuring the availability of essential drugs for military healthcare operations. The specific scope includes the delivery of these pharmaceutical vials to a designated location within a concise performance window. This delivery order is part of a larger, indefinite delivery contract that Fresenius Kabi secured through competitive bidding for providing critical medical supplies to the DoD. The timeline for this delivery order is brief, covering a few days in early March 2026, facilitating prompt fulfillment of medical product requirements. This award underlines the strategic importance of maintaining a reliable supply chain of critical pharmaceuticals to support national defense efforts.
Description
4571084395!KETOROLAC 30 MG/ML VIALML